Syncom Formulations India Ltd (SYFI)

BSE
Currency in INR
17.74
-0.51(-2.79%)
Closed
SYFI Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
17.2318.46
52 wk Range
11.0027.94
Key Statistics
Edit
Bid/Ask
17.55 / 17.74
Prev. Close
17.74
Open
18.46
Day's Range
17.23-18.46
52 wk Range
11-27.94
Volume
697.26K
Average Volume (3m)
441.94K
1-Year Change
53.1%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SYFI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Syncom Formulations India Company Profile

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties. It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Employees
998
Market
India

Compare SYFI to Peers and Sector

Metrics to compare
SYFI
Peers
Sector
Relationship
P/E Ratio
43.8x22.5x−0.5x
PEG Ratio
1.520.350.00
Price/Book
5.5x2.3x2.6x
Price / LTM Sales
4.4x1.6x3.0x
Upside (Analyst Target)
-7.3%55.6%
Fair Value Upside
Unlock3.6%10.1%Unlock

Earnings

Latest Release
Feb 13, 2023
EPS / Forecast
0.06 / --
Revenue / Forecast
573.80M / --
EPS Revisions
Last 90 days

FAQ

What Is the Syncom Formulations India (SYFI) Stock Price Today?

The Syncom Formulations India stock price today is 17.74.

What Stock Exchange Does Syncom Formulations India Trade On?

Syncom Formulations India is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Syncom Formulations India?

The stock symbol for Syncom Formulations India is "SYFI."

Does Syncom Formulations India Pay Dividends? What’s The Current Dividend Yield?

The Syncom Formulations India dividend yield is 0.34%.

What Is the Syncom Formulations India Market Cap?

As of today, Syncom Formulations India market cap is 16.68B.

What is Syncom Formulations India Earnings Per Share?

The Syncom Formulations India EPS is 0.398.

From a Technical Analysis Perspective, Is SYFI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.